Tenax Therapeutics, Inc.
Status: Publicly traded
Direct answer
Tenax Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TENX.
Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary...
Can you invest in Tenax Therapeutics, Inc.?
Yes. Tenax Therapeutics, Inc. trades publicly on NASDAQ as TENX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Tenax Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.